Home
>
National Drug Code (NDC)
>
Acyclovir
Acyclovir - 33261-227-16 - (Acyclovir)
Drug Information of Acyclovir
| Product NDC: | 33261-227 |
| Proprietary Name: | Acyclovir |
| Non Proprietary Name: | Acyclovir |
| Active Ingredient(s): | 800 mg/1 & nbsp; Acyclovir |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Acyclovir
| Product NDC: | 33261-227 |
| Labeler Name: | Aidarex Pharmaceuticals LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074556 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19970430 |
Package Information of Acyclovir
| Package NDC: | 33261-227-16 |
| Package Description: | 16 TABLET in 1 BOTTLE (33261-227-16) |
NDC Information of Acyclovir
| NDC Code | 33261-227-16 |
| Proprietary Name | Acyclovir |
| Package Description | 16 TABLET in 1 BOTTLE (33261-227-16) |
| Product NDC | 33261-227 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Acyclovir |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19970430 |
| Marketing Category Name | ANDA |
| Labeler Name | Aidarex Pharmaceuticals LLC |
| Substance Name | ACYCLOVIR |
| Strength Number | 800 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient] |
